Skip to main content
SpringerLink
Log in

Practical breast carcinoma cell kinetics: Review and update

  • 6th Annual San Antonio Breast Cancer Symposium
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

The S-phase fraction (SPF) measured by flow cytometry of DNA and the thymidine labeling index (TLI) measured autoradiographically indicate the proportion of carcinoma cells currently synthesizing DNA and reflect the rate of proliferation. The TLI and SPF are lognormally distributed. The median TLI performed to maximize precursor uptake is near 5% (5 labeled carcinoma cells per 100), the mean near 7%, and the range from less than 1% to near 40%. Corresponding values for the SPF measured by DNA flow cytometry are slightly higher when appropriate measures are taken to reduce background debris counts and other artefacts. Residual elevation of SPF above TLI may result from S-phase arrested cells. Flow cytometric histograms show that clearly aneuploid cell lines exist in 50–80% of primary breast carcinomas. Aneuploid breast carcinomas have higher mean TLI than diploid breast carcinomas, and therefore proliferate more rapidly. They also more frequently lack estrogen receptor (ER). Carcinomas with minimal nuclear anaplasia, particularly those of tubular, mucinous, infiltrating lobular and adenocystic types have low TLI and SPF, whereas carcinomas with highly anaplastic nuclei, including medullary carcinomas, have high TLI and SPF. TLI and SPF correlate inversely with ER and PgR content, have no relationship to axillary lymph nodal status, and have a weak positive correlation with tumor size and a weak negative correlation with age. High TLI predicts a high risk of early relapse after primary therapy for both node-negative and node-positive carcinomas. Carcinomas that produce brain metastases have particularly high TLI. Current evidence suggests that high SPF and aneuploidy may prove to have prognostic significance like TLI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Steel GG: Growth Kinetics of Tumours. Clarendon Press, Oxford, 1977

    Google Scholar 

  2. Meyer JS: Growth and cell kinetic measurements in human tumors. Pathol Annu 16 (Part 2):53–81, 1981

    PubMed  Google Scholar 

  3. Hamilton E, Dobbin J: The percentage labelled mitosis technique shows the mean cell cycle time to be half its true value in carcinoma NT. II. [3H] deoxyuridine studies. Cell Tissue Kinet 16:483–492, 1983

    PubMed  Google Scholar 

  4. Taylor JH, Woods PS, Hughes WL: The organization and duplication of chromosomes using tritium-labeled thymidine. Proc Natl Acad Sci USA 43:122–128, 1957

    Google Scholar 

  5. Braylan RC: Flow cytometry. Arch Pathol Lab Med 107:1–6, 1983

    PubMed  Google Scholar 

  6. Stenkvist B, Bengtsson E, Eriksson O, Jarkraus T, Nordin B, Westmann-Naeser S: Correlation between cytometric features and mitotic frequency in human breast carcinoma. Cytometry 1:287–291, 1981

    PubMed  Google Scholar 

  7. Bloom HJG, Richardson WW: Histologic grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359–377, 1957

    PubMed  Google Scholar 

  8. Meyer JS: Cytokinetic analysis of breast carcinoma. Implications for adjuvant cytotoxic therapy of node-negative patients.In Blumenschein GR (ed): Current Controversies in Breast Cancer. Proceedings of the 26th Annual Clinical Conference on Cancer (in press)

  9. Meyer JS, Hixon B: Advanced stage and early relapse of breast carcinomas associated with high thymidine labeling indices. Cancer Res 39:4042–4047, 1979

    Google Scholar 

  10. Meyer JS, Connor RE: In vitro labeling of solid tissues with tritiated thymidine for autoradiographic detection of S-phase nuclei. Stain Technol 52:185–195, 1977

    PubMed  Google Scholar 

  11. Dörmer P, Brinkmann W, Born R, Steel GG: Rate and time of DNA synthesis of individual Chinese hamster cells. Cell Tissue Kinet 8:399–412, 1975

    PubMed  Google Scholar 

  12. Meyer JS, Facher R: Thymidine labeling index of human breast carcinoma. Enhancement of in vitro labeling by 5-fluorouracil and 5-fluoro-2′-deoxyuridine. Cancer 39: 2524–2532, 1977

    PubMed  Google Scholar 

  13. Gentili C, Sanfilippo O, Silvestrini R: Cell proliferation and its relationship to clinical features and relapse in breast cancers. Cancer 48:974–979, 1981

    PubMed  Google Scholar 

  14. Meyer JS, Bauer WC, Rao BR: Subpopulations of breast carcinoma defined by S-phase fraction, morphology, and estrogen receptor content. Lab Invest 29:225–235, 1978

    Google Scholar 

  15. Meyer JS, Micko S, Craver JL, McDivitt RW: DNA flow cytometry of breast carcinoma after acetic-acid fixation. Cell Tissue Kinet (in press)

  16. Straus MJ, Moran R, Muller RE, Wotiz HH: Estrogen receptor heterogeneity and the relationship between estrogen receptor and the tritiated thymidine labeling index in human breast cancer. Oncology 39:197–200, 1982

    PubMed  Google Scholar 

  17. Silvestrini R, Diadone MG, Di Fronzo G: Relationship between proliferative activity and estrogen receptors in breast cancer. Cancer 44:665–670, 1979

    PubMed  Google Scholar 

  18. Kute TE, Muss HB, Anderson D, Crumb K, Miller B, Burns D, Dube LA: Relationship of steroid receptor, cell kinetics and clinical status in patients with breast cancer. Cancer Res 41:3524–3529, 1981

    Google Scholar 

  19. Raber MN, Barlogie B, Latreille J, Bedrossian C, Fritsche H, Blumenschein G: Ploidy, proliferative activity and estrogen receptor content in human breast cancer. Cytometry 3:36–41, 1982

    PubMed  Google Scholar 

  20. McDivitt RW, Stone KR, Meyer JS: A method for dissociation of viable human breast cancer that produces flow cytometric kinetic information similar to that obtained by thymidine labeling (submitted to Cancer Res)

  21. Jakobsen A: The use of trout erythrocytes and human lymphocytes for standardization in flow cytometry. Cytometry 4:161–165, 1983

    PubMed  Google Scholar 

  22. Olszewski W, Darzynkiewicz Z, Rosen PP, Schwartz MK, Melamed MR: Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor. Cancer 48:980–984, 1981

    PubMed  Google Scholar 

  23. Taylor IW, Musgrove EA, Friedlander ML, Foo M, Hedley DW: The influence of age on the DNA ploidy levels of breast tumors. Eur J Cancer Clin Oncol 19:623–628, 1983

    PubMed  Google Scholar 

  24. Bichel P, Poulsen HS, Andersen J: Estrogen receptor content and ploidy of human mammary carcinoma. Cancer 50:1771–1774, 1982

    PubMed  Google Scholar 

  25. Haag D: Flow microfluorometric deoxyribonucleic acid (DNA) analysis supplementing routine histopathologic diagnosis of biopsy specimens. Lab Invest 42:85–90, 1982

    Google Scholar 

  26. Baisch H, Beck H-P, Christensen IJ, Hartmann NR, Fried J, Neal PN, Gray JW, Jett JH, Johnston DA, White RA, Nicolini C, Zeitz S, Watson JV: Comparison of evaluation methods for DNA histograms measured by flow cytometry.In Laerum OD, Lindmo T, Thorud E (eds): Flow Cytometry IV. Universitetsforlaget, Bergen, 1980, pp 152–158

    Google Scholar 

  27. Darzynkiewicz Z, Traganos F, Melamed MR: New cell cycle compartments identified by multiparameter flow cytometry. Cytometry 1:98–108, 1980

    PubMed  Google Scholar 

  28. Allison DC, Yuhas JM, Ridolpho PF, Anderson S, Johnson TS: Cytophotometric measurement of the cellular DNA content of [3H]thymidine-labelled spheroids. Demonstration that some non-labelled cells have S and G2 DNA content. Cell Tissue Kinet 16:237–246, 1983

    PubMed  Google Scholar 

  29. Auer GU, Caspersson TO, Wallgren AS: DNA content and survival in mammary carcinoma. Anal Quant Cytol 2:161–165, 1980

    PubMed  Google Scholar 

  30. Atkin NB: Modal deoxyribonucleic acid value and survival in carcinoma of the breast. Br Med J 1:271–272, 1972

    Google Scholar 

  31. Wolley RC, Schreiber K, Koss LG, Karas M, Sherman A: DNA distribution in human colon carcinomas and its relationship to clinical behavior. JNCI 69:15–22, 1982

    PubMed  Google Scholar 

  32. Meyer JS, Friedman E, McCrate M, Bauer WC: Prediction of early course of breast carcinoma by thymidine labeling. Cancer 51:1879–1886, 1983

    PubMed  Google Scholar 

  33. Tubiana M, Pejovic JM, Renaud A, Contesso G, Chavaudra N, Gioanni J, Malaise EP: Kinetic parameters and the course of the disease in breast cancer. Cancer 47:937–043, 1981

    PubMed  Google Scholar 

  34. Meyer JS, Rao BR, Stevens SC, White WL: Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication. Cancer 40:2290–2298, 1978

    Google Scholar 

  35. Sears HF, Janus C, Levy W, Hopson R, Creech R, Grotzinger P: Breast cancer without axillary metastases. Are there high risk biologic subpopulations? Cancer 50:1820–1827, 1982

    PubMed  Google Scholar 

  36. Blamey RW, Bishop HM, Blake JRS, Doyle PJ, Elston CW, Haybittle JL, Nicholson RI, Griffiths K: Relationship between primary breast tumor receptor status and patient survival. Cancer 46:2765–2769, 1980

    PubMed  Google Scholar 

  37. Hähnel R, Woodings T, Vivian AB: Prognostic value of estrogen receptors in primary breast cancer. Cancer 44:671–675, 1979

    PubMed  Google Scholar 

  38. Shapiro CM, Schifeling D, Bitran JD, Desser RK, Rochman H, Michel A, Shapiro R, Evans R, Kozloff MF, Recant W, Billings AA: Prognostic value of the estrogen receptor level in pathologic stage I and II adenocarcinoma of the breast. J Surg Oncol 19:119–121, 1982

    PubMed  Google Scholar 

  39. Samaan NA, Buzdar AU, Aldinger KA, Schultz PN, Yang K-P, Romsdahl MM, Martin R: Estrogen receptor: a prognostic factor in breast cancer. Cancer 47:554–560, 1981

    PubMed  Google Scholar 

  40. Kinne DW, Ashikari R, Butler A, Menendez-Botet C, Rosen PP, Schwartz M: Estrogen receptor protein in breast cancer as a predictor of recurrence. Cancer 47:2364–2367, 1981

    PubMed  Google Scholar 

  41. Howat JMT, Barnes DM, Harris M, Swindell R: The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease. Br J Cancer 47:629–640, 1983

    PubMed  Google Scholar 

  42. Croton R, Cooke T, Holt S, George WD, Nicolson R, Griffiths K: Oestrogen receptors and survival in early breast cancer. Br Med J [Clin Res] 283:1289–1291, 1981

    Google Scholar 

  43. Crowe JP, Hubay CA, Pearson OH, Marshall JS, Rosenblatt J, Mansour EG, Hermann RE, Jones JC, Flynn WJ, McGuire WL and participating investigators: Estrogen receptor as a prognostic indicator for stage I breast cancer patients. Breast Cancer Res Treat 2:171–176, 1982

    PubMed  Google Scholar 

  44. Allegra JC, Lippman ME, Simon R, Thompson EB, Barlock A, Green L, Huff K, Do HMT, Aitken SC, Warren R: Association between steroid hormone receptor status and disease-free interval in breast cancer. Cancer Treat Rep 63:1271–1277, 1979

    PubMed  Google Scholar 

  45. Meyer JS, Lee JY: Relationships of S-phase fraction of breast carcinoma in relapse to duration of remission, estrogen receptor content, therapeutic responsiveness, and duration of survival. Cancer Res 40:1890–1896, 1980

    Google Scholar 

  46. Bertuzzi A, Diadone MG, Di Fronzo G, Silvestrini R: Relationship among estrogen receptors, proliferative activity and menopausal status in breast cancer. Breast Cancer Res Treat 1:253–262, 1981

    PubMed  Google Scholar 

  47. Allegra JC: Methotrexate and 5-fluorouracil following tamoxifen and premarin in advanced breast cancer. Semin Oncol 10, No. 2 (Suppl 2):23–28, 1983

    Google Scholar 

  48. Brünner N, Spang-Thomsen M, Vindelov L, Nielson A: Effect of 17β-oestradiol on growth curves and flow cytometric DNA distribution of two human breast carcinomas grown in nude mice. Br J Cancer 47:641–647, 1983

    PubMed  Google Scholar 

  49. Sutherland RL, Reddel RR, Green MD: Effects of oestrogens on cell proliferation and cell cycle kinetics. A hypothesis on the cell cycle effects of antioestrogens. Eur J Cancer Clin Oncol 19:307–318, 1983

    PubMed  Google Scholar 

  50. Post J, Sklarew RH, Hoffman J: The proliferative patterns of human breast cancer cells in vivo. Cancer 39:1500–1507, 1977

    PubMed  Google Scholar 

  51. Nordenskjöld B, Zetterberg A, Löwhagen T: Measurement of DNA synthesis by3H-thymidine incorporation into needle aspirates from human tumors. Acta Cytol 18: 215–221, 1974

    PubMed  Google Scholar 

  52. Silvestrini R, Sanfilippo O, Tendesco G: Kinetics of human mammary carcinomas and their correlation with the cancer and the host characteristics. Cancer 34:1252–1258, 1974

    PubMed  Google Scholar 

  53. Sklarew RJ, Hoffman J, Post J: A rapid in vitro method for measuring cell proliferation in human breast cancer. Cancer 40:2299–2302, 1977

    PubMed  Google Scholar 

  54. Schiffer LM, Braunschweiger PG, Stragand JJ, Poulakos L: The cell kinetics of human mammary cancers. Cancer 43:1707–1719, 1979

    PubMed  Google Scholar 

  55. Straus MJ, Moran RE: The cell cycle kinetics of human breast cancer. Cancer 46:2634–2639, 1980

    PubMed  Google Scholar 

  56. Auer GU, Caspersson TO, Gustafsson SA, Humla SA, Ljung B-M, Nordenskjöld B, Silverswärd C, Wallgren AS: Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas. Anal Quant Cytol 2:280–284, 1980

    PubMed  Google Scholar 

  57. Fossa SD, Marton PF, Knudsen OS, Kaalhus O, Bormer O, Vagge S: Nuclear Feulgen DNA content and nuclear size in human breast carcinoma. Hum Pathol 13:626–630, 1982

    PubMed  Google Scholar 

  58. Olszewski W, Darzynkiewicz Z, Rosen PP, Schwarz MK, Melamed MR: Flow cytometry of breast carcinoma: II. Relation of tumor cell cycle distribution to histology and estrogen receptor. Cancer 48:985–988, 1981

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, The Jewish Hospital of St. Louis and Washington University School of Medicine, 63110, St. Louis, MO, USA

    John Strauch Meyer, Robert W. McDivitt, Kenneth R. Stone, Marianne U. Prey & Walter C. Bauer

Authors
  1. John Strauch Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert W. McDivitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kenneth R. Stone
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marianne U. Prey
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Walter C. Bauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meyer, J.S., McDivitt, R.W., Stone, K.R. et al. Practical breast carcinoma cell kinetics: Review and update. Breast Cancer Res Tr 4, 79–88 (1984). https://doi.org/10.1007/BF01806389

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01806389

Keywords

Search

Navigation